Buy, hold, sell: Minerals 260, 4DMedical, Karoon Energy shares

Two experts share their latest ratings and opinions on three ASX shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are down 0.1% to 8,676.8 points on Thursday.

Today marks the eighth consecutive day of falls for the Australian share market amid no signs of progress in the Middle East.

Investors are also still digesting yesterday's news that annual inflation increased up from 3.7% in February to 4.6% in March.

The spike was largely due to the war in Iran and a 33% monthly increase in automotive fuel prices. 

Meanwhile on the The Bull this week, two experts have shared their latest ratings and opinions on three ASX shares.

Let's check them out.

A woman wearing a black and white striped t-shirt looks to the sky with her hand to her chin, contemplating buying ASX shares.

Image source: Getty Images

Minerals 260 Ltd (ASX: MI6)

The Minerals 260 share price is 72 cents, down 3.7% today but up a staggering 455% over 12 months.

Jonathan Tacadena from MPC Markets thinks there is more growth ahead for this ASX mining share

Tacadena said:

This miner recently signed a $220 million strategic funding agreement with gold royalty company Franco-Nevada Corporation to accelerate and de-risk the development of its 4.5 million ounce Bullabulling Gold project in Western Australia.

The agreement puts MI6 firmly in the developer category of gold companies.

With a maiden ore reserve and an updated mineral resource estimate due in mid 2026, we like the chances of a re-rating for MI6.

4DMedical Ltd (ASX: 4DX)

The 4DMedical share price is $4.19, down 1.2% today.

This ASX 200 healthcare share has leapfrogged 1,210% over 12 months.

Stuart Bromley from Medallion Financial Group says it's best to simply sit on this stock for now.

Bromley said:

4DX is a respiratory imaging technology company, with a strong regulatory moat in the United States.

In a relatively short time since the US Food and Drug Administration approved its CT:VQ product, US hospitals are adopting it, including the highly renowned Mayo Clinic.

Also, 4DX has been included in the S&P/ASX200 Index, which should generate more interest in the company.

Being in the ASX 200 means fundies managing popular index-tracking exchange-traded funds (ETFs) are consistently buying the stock.

Karoon Energy Ltd (ASX: KAR)

The Karoon Energy share price is $2.15, up 0.2% today and up 38% in the year to date (YTD).

Soaring oil and gas prices due to the Iran war have led to significant recent share price growth for this oil and gas explorer.

Karoon Energy shares have ripped from $1.54 on 27 February, just before the war began, to $2.15 today — an increase of 40%.

Bromley says ordinary investors should follow Medallion's lead and take profits on this ASX energy share

He said:

In our view, Karoon has benefited from increasing crude oil prices since the conflict in the Middle East started on February 28.

We believe these sorts of opportunities should be taken and we have locked in profits on Karoon.

Bromley pointed out that Karoon Energy reported a 19% fall in revenue, along with a 2% decline in net profit after tax (NPAT), for FY25.

The analyst also recommends that investors take profits on another ASX energy share — find out which one here.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Stressed man in an an office with his eyes closed and phone in his hand, with investing graphs open on two iMacs.
Broker Notes

Why Bell Potter just downgraded this popular ASX 200 stock

The broker is feeling cautious about this fallen giant.

Read more »

Image of a fist holding two yellow lightning bolts against a red backdrop.
Broker Notes

How high do brokers think AGL shares will go?

Is the power company looking undervalued?

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Broker Notes

Up 250%! Broker tips this dividend paying ASX All Ords tech stock for more outsized gains

A top broker forecasts more outperformance from this dividend paying ASX tech stock.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Up 73%! 3 reasons I'd still buy Mineral Resources shares today

A leading expert forecasts more outperformance from Mineral Resources' surging shares.

Read more »

Friends in a 4WD.
Broker Notes

Following its results, Macquarie is tipping 80% upside for this ASX 300 stock

This parts supplier appears primed for share price growth.

Read more »

Happy mum and dad with daughter smiling on couch after relocation to new home.
Broker Notes

After crashing 19% this broker says Life360 shares are a buy

Investors should consider buying the dip after yesterday's sell-off.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on NAB shares

A leading expert forecasts growing headwinds for NAB shares. But why?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Bell Potter names 3 ASX shares to buy after results

The broker is bullish on these names. Here's what it is recommending.

Read more »